Table 1 of
Xu, Mol Vis 2019; 25:834-842. Table 1 of
Xu, Mol Vis 2019; 25:834-842.
Table 1. Clinical characteristics of the investigated VKH patients used for the first- and second-stage studies.
| Clinical characteristics | VKH patients in the first stage (total=600) | % | VKH patients in Second stage (total=259) | % |
|---|---|---|---|---|
| Age at onset (years ± SD) | 38.74±13.44 | 41.96±14.21 | ||
| Males | 327 | 54.50 | 148 | 57.1 |
| Females | 273 | 45.50 | 111 | 42.9 |
| Headache | 244 | 40.67 | 120 | 46.33 |
| Alopecia | 240 | 40.00 | 94 | 36.29 |
| Poliosis | 232 | 38.67 | 100 | 38.61 |
| Vitiligo | 106 | 17.67 | 48 | 18.53 |
| Tinnitus | 274 | 45.67 | 126 | 48.65 |
| Neck stiffness | 70 | 11.67 | 34 | 13.13 |
| Dysacusia | 188 | 31.33 | 101 | 38.40 |
| Scalp hypersensitivity | 94 | 15.67 | 40 | 15.44 |